Trexquant Investment LP Has $1.20 Million Stake in Select Medical Holdings Corporation $SEM

Key Points

• Trexquant Investment LP has reduced its stake in Select Medical Holdings Corporation by 50.5%, selling 73,233 shares and now owns approximately 0.06% of the company valued at $1.2 million.
• Several institutional investors have increased their holdings in Select Medical, with Price T Rowe Associates and Vanguard Group among those significantly enhancing their positions.
• Select Medical reported earnings per share of $0.32 for the last quarter, exceeding analysts' expectations, while the company also declared a quarterly dividend of $0.0625 per share.

Trexquant Investment LP lessened its position in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 50.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 71,880 shares of the health services provider's stock after selling 73,233 shares during the quarter. Trexquant Investment LP owned about 0.06% of Select Medical worth $1,200,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd increased its holdings in shares of Select Medical by 61.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider's stock worth $45,000 after purchasing an additional 1,030 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Select Medical during the 1st quarter worth about $60,000. GAMMA Investing LLC increased its holdings in shares of Select Medical by 217.4% during the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock worth $109,000 after purchasing an additional 4,453 shares during the period. Lazard Asset Management LLC increased its holdings in shares of Select Medical by 47.8% during the 4th quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock worth $130,000 after purchasing an additional 2,255 shares during the period. Finally, Wealthquest Corp bought a new position in shares of Select Medical during the 1st quarter worth about $143,000. Institutional investors own 89.48% of the company's stock.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Bank of America lowered their target price on shares of Select Medical from $18.00 to $15.00 and set a "buy" rating on the stock in a research note on Wednesday. UBS Group reissued a "neutral" rating and issued a $14.00 target price (down previously from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Select Medical has a consensus rating of "Moderate Buy" and a consensus price target of $19.20.

Select Medical Price Performance

NYSE:SEM traded down $0.13 on Friday, reaching $12.68. The stock had a trading volume of 29,167 shares, compared to its average volume of 1,117,500. The company has a market capitalization of $1.57 billion, a P/E ratio of 11.92, a price-to-earnings-growth ratio of 0.51 and a beta of 1.25. Select Medical Holdings Corporation has a 1-year low of $11.65 and a 1-year high of $40.98. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.92. The stock has a fifty day moving average price of $13.46 and a 200-day moving average price of $15.17.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.04. The firm had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.35 billion. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The company's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.60 earnings per share. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Research analysts forecast that Select Medical Holdings Corporation will post 1.17 EPS for the current year.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th were given a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date was Wednesday, August 13th. Select Medical's dividend payout ratio is presently 23.58%.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.